Skip to main content

Published locations for Bendamustine plus rituximab may have edge for treating indolent NHL, MCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Bendamustine plus rituximab may have edge for treating indolent NHL, MCL

User login

  • Reset your password
  • /content/bendamustine-plus-rituximab-may-have-edge-treating-indolent-nhl-mcl
  • /hematologynews/article/141014/mantle-cell-lymphoma/bendamustine-plus-rituximab-may-have-edge
  • /oncologypractice/article/141014/mantle-cell-lymphoma/bendamustine-plus-rituximab-may-have-edge
  • /hematologynews/nhlhub/article/141014/mantle-cell-lymphoma/bendamustine-plus-rituximab-may-have-edge
  • /hematology-oncology/article/141014/mantle-cell-lymphoma/bendamustine-plus-rituximab-may-have-edge
  • /b-cell-lymphoma-icymi/article/141014/mantle-cell-lymphoma/bendamustine-plus-rituximab-may-have-edge